Anti-vascular endothelial growth factor for proliferative diabetic retinopathy
Editorial Group: Cochrane Eyes and Vision Group
Published Online: 8 SEP 2010
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Martinez-Zapata MJ, Martí-Carvajal AJ, Solà I, Pijoán JI, Buil-Calvo JA. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 9. Art. No.: CD008721. DOI: 10.1002/14651858.CD008721.
- Publication Status: New
- Published Online: 8 SEP 2010
This is the protocol for a review and there is no abstract. The objectives are as follows:
The primary objective is to determine the efficacy of selective vascular endothelial growth factor inhibitors (anti-VEGFs) for treating patients with proliferative diabetic retinopathy (DR).
The secondary objective is to assess the safety of selective anti-VEGFs for treating patients with proliferative DR.